Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Other Non-Current Assets (2019 - 2025)

Historic Other Non-Current Assets for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $9.7 million.

  • Harmony Biosciences Holdings' Other Non-Current Assets rose 5514.65% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 5514.65%. This contributed to the annual value of $6.2 million for FY2024, which is 225.47% down from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Other Non-Current Assets stood at $9.7 million, which was up 5514.65% from $5.5 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Other Non-Current Assets registered a high of $9.7 million during Q3 2025, and its lowest value of $750000.0 during Q1 2021.
  • Over the past 5 years, Harmony Biosciences Holdings' median Other Non-Current Assets value was $3.4 million (recorded in 2022), while the average stood at $4.2 million.
  • The largest annual percentage gain for Harmony Biosciences Holdings' Other Non-Current Assets in the last 5 years was 36866.67% (2021), contrasted with its biggest fall of 4710.86% (2021).
  • Quarter analysis of 5 years shows Harmony Biosciences Holdings' Other Non-Current Assets stood at $3.5 million in 2021, then decreased by 20.4% to $2.8 million in 2022, then skyrocketed by 125.09% to $6.3 million in 2023, then fell by 2.25% to $6.2 million in 2024, then skyrocketed by 57.44% to $9.7 million in 2025.
  • Its Other Non-Current Assets was $9.7 million in Q3 2025, compared to $5.5 million in Q2 2025 and $5.9 million in Q1 2025.